Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta)

Neuroreport. 1997 Dec 1;8(17):3833-6. doi: 10.1097/00001756-199712010-00034.

Abstract

Increasing evidence suggests the involvement of the basal ganglia in HIV-1-infected patients. We used SIV-macaques, an animal model of HIV-1 infection, to investigate changes in CSF biogenic amine metabolites over time and compared them with control animals. The dopamine and serotonin metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), were analysed by reverse-phase chromatography with electrochemical detection. DOPAC concentrations were significantly increased in SIV-infected animals compared with controls. 5-HIAA and HVA remained unchanged. However, the longitudinal assessment of metabolites up to 3 months post-infection revealed a significant increase in 5-HIAA. Our results reflect the effects of SIV early stage infection on monoamine systems in brain and further validate the simian model for AIDS research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / cerebrospinal fluid
  • Acquired Immunodeficiency Syndrome / cerebrospinal fluid*
  • Animals
  • Biogenic Amines / cerebrospinal fluid*
  • Dopamine / cerebrospinal fluid
  • Electrochemistry / methods
  • HIV-1
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Macaca mulatta
  • Reference Values
  • Serotonin / cerebrospinal fluid
  • Simian Immunodeficiency Virus
  • Time Factors

Substances

  • Biogenic Amines
  • 3,4-Dihydroxyphenylacetic Acid
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Dopamine
  • Homovanillic Acid